PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33043320-1	2020	Ibrutinib, a known Burton"s tyrosine kinase (BTK) and interleukin-2 inducible T-cell kinase (ITK) inhibitor, is used for the treatment of B-cell disorders (chronic lymphocytic leukemia [CLL] and various other lymphomas) and chronic graft versus host disease following allogeneic hematopoietic cell transplantation.	ibrutinib	0-9	IL2 inducible T cell kinase	Homo sapiens	54-91	
33043320-1	2020	Ibrutinib, a known Burton"s tyrosine kinase (BTK) and interleukin-2 inducible T-cell kinase (ITK) inhibitor, is used for the treatment of B-cell disorders (chronic lymphocytic leukemia [CLL] and various other lymphomas) and chronic graft versus host disease following allogeneic hematopoietic cell transplantation.	ibrutinib	0-9	IL2 inducible T cell kinase	Homo sapiens	93-96